Patents Assigned to NIRvana Sciences
  • Patent number: 11999885
    Abstract: Provided are fluorescent microparticles and/or nanoparticles that have a polymeric matrix and at least one porphyrinic macrocycle associated therewith. The porphyrinic macrocycles associated with the presently disclosed fluorescent microparticles and/or nanoparticles are in some embodiments selected from the group consisting of porphyrins (including 17,18-didehydrophorbines), chlorins (including phorbines), bacteriochlorins (including bacteriophorbines), and isobacteriochlorins (including isobacteriochlorins containing a fused ā€œEā€ ring). In some embodiments, the porphyrinic macrocycles have structures selected from Formulas I and H.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: June 4, 2024
    Assignee: NIRVANA SCIENCES INC.
    Inventors: James Bruce Pitner, Rosemary B. Evans-Storms, Duane A. Olsen
  • Publication number: 20240082431
    Abstract: Provided are photoacoustic imaging contrast agents that include at least one radiation-absorbing component comprising a copper-complexed and/or manganese-complexed chlorin and/or bacteriochlorin and/or a derivative thereof, or a combination thereof. Also provided are methods for using the disclosed photoacoustic imaging contrast agents either singly or in combination for generating an image of a volume, optionally a subject or a body part, cell, tissue, or organ thereof. Further provided are compositions and methods for multiplex photoacoustic imaging of a volume, optionally a subject or a body part, cell, tissue, or organ thereof using photoacoustic imaging contrast agents that include a plurality of the presently disclosed copper-complexed and/or manganese-complexed chlorins and/or bacteriochlorins and/or derivatives thereof simultaneously.
    Type: Application
    Filed: January 4, 2022
    Publication date: March 14, 2024
    Applicant: NIRvana Sciences, Inc.
    Inventors: James Bruce Pitner, Russell D. Thomas, Joshua O. Akhigbe
  • Patent number: 11904026
    Abstract: Provided are photoacoustic imaging contrast agents that include at least one radiation-absorbing component comprising a copper-complexed and/or manganese-complexed chlorin and/or bacteriochlorin and/or a derivative thereof, or a combination thereof. Also provided are methods for using the disclosed photoacoustic imaging contrast agents either singly or in combination for generating an image of a volume, optionally a subject or a body part, cell, tissue, or organ thereof. Further provided are compositions and methods for multiplex photoacoustic imaging of a volume, optionally a subject or a body part, cell, tissue, or organ thereof using photoacoustic imaging contrast agents that include a plurality of the presently disclosed copper-complexed and/or manganese-complexed chlorins and/or bacteriochlorins and/or derivatives thereof simultaneously.
    Type: Grant
    Filed: January 4, 2021
    Date of Patent: February 20, 2024
    Assignee: NIRvana Sciences Inc.
    Inventors: James Bruce Pitner, Russell D. Thomas, Joshua O. Akhigbe
  • Publication number: 20220249708
    Abstract: Provided are bacteriochlorin derivatives with narrow band emission. In some embodiments, the bacteriochlorin derivatives are PEGylated. In some embodiments, the bacteriochlorin derivatives have high water solubility (e.g., 10 mg/mL or more). In some embodiments the bacteriochlorin derivatives are PEGylated and have high water solubility. The bacteriochlorin derivatives can include bioconjugatable groups for forming conjugates, for example, with antibodies and nanoparticles. The bacteriochlorin derivatives and their conjugates can be used in imaging and therapeutic applications. Methods of synthesizing the bacteriochlorin derivatives are also provided.
    Type: Application
    Filed: May 19, 2020
    Publication date: August 11, 2022
    Applicant: NIRvana Sciences Inc.
    Inventors: Christopher J. MacNevin, Chih-Yuan Chen
  • Publication number: 20220249707
    Abstract: Provided are chlorin derivatives with narrow band emission. In some embodiments, the bacteriochlorin derivatives are PEGylated. In some embodiments, the chlorin derivatives have high water solubility (e.g., 10 mg/mL or more). In some embodiments, the chlorin derivatives are PEGylated and have high water solubility. The chlorin derivatives can include bioconjugatable groups for forming conjugates, for example, with antibodies and nanoparticles. The chlorin derivatives and their conjugates can be used in imaging and therapeutic applications. Methods of synthesizing the chlorin derivatives are also provided.
    Type: Application
    Filed: May 19, 2020
    Publication date: August 11, 2022
    Applicant: NIRvana Sciences Inc.
    Inventors: Christopher J. MacNevin, James Bruce Pitner, Chih-Yuan Chen
  • Publication number: 20210361783
    Abstract: Provided are photoacoustic imaging contrast agents that include at least one radiation-absorbing component comprising a copper-complexed and/or manganese-complexed chlorin and/or bacteriochlorin and/or a derivative thereof, or a combination thereof. Also provided are methods for using the disclosed photoacoustic imaging contrast agents either singly or in combination for generating an image of a volume, optionally a subject or a body part, cell, tissue, or organ thereof. Further provided are compositions and methods for multiplex photoacoustic imaging of a volume, optionally a subject or a body part, cell, tissue, or organ thereof using photoacoustic imaging contrast agents that include a plurality of the presently disclosed copper-complexed and/or manganese-complexed chlorins and/or bacteriochlorins and/or derivatives thereof simultaneously.
    Type: Application
    Filed: January 4, 2021
    Publication date: November 25, 2021
    Applicant: NIRvana Sciences Inc.
    Inventors: James Bruce Pitner, Russell D. Thomas, Joshua O. Akhigbe
  • Publication number: 20200009272
    Abstract: Provided are photoacoustic imaging contrast agents that include at least one radiation-absorbing component comprising a bacteriochlorin, a metallobacteriochlorin, a derivative thereof, or a combination thereof. Also provided are methods for using the disclosed photoacoustic imaging contrast agents either singly or in combination for generating an image of a volume, optionally a subject or a body part, cell, tissue, or organ thereof. Further provided are compositions and methods for multiplex photoacoustic imaging of a volume, optionally a subject or a body part, cell, tissue, or organ thereof using photoacoustic imaging contrast agents that include a plurality of the presently disclosed bacteriochlorins, metallobacteriochlorins, and/or derivatives thereof simultaneously.
    Type: Application
    Filed: February 2, 2018
    Publication date: January 9, 2020
    Applicant: NIRvana Sciences Inc.
    Inventors: James Bruce Pitner, Rajalekha Manjakuppam Rajamahendiran, Russell D. Thomas
  • Publication number: 20190264102
    Abstract: Provided are fluorescent microparticles and/or nanoparticles that have a polymeric matrix and at least one porphyrinic macrocycle associated therewith. The porphyrinic macrocycles associated with the presently disclosed fluorescent microparticles and/or nanoparticles are in some embodiments selected from the group consisting of porphyrins (including 17,18-didehydrophorbines), chlorins (including phorbines), bacteriochlorins (including bacteriophorbins), and isobacteriochlorins (including isobacteriochlorins containing a fused ā€œEā€ ring). In some embodiments, the porphyrinic macrocycles have structures selected from Formulas I and H.
    Type: Application
    Filed: June 12, 2017
    Publication date: August 29, 2019
    Applicant: NIRvana Sciences
    Inventors: James Bruce Pitner, Rosemary B. Evans-Storms, Duane A. Olsen